BioNTech SE Sales And Marketing Expense
BioNTech SE (BNTX) reported Sales And Marketing Expense of EUR 110.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2026-03-10
| Period end | Sales And Marketing Expense 12 month | Sales And Marketing Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | 110.00M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 67.90M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 62.70M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 59.50M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 50.40M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 14.50M EUR 20-F · filed 2023-03-27 | 14.51M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 2.70M EUR 20-F/A · filed 2022-10-26 | 2.72M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 3.04M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 6.60M EUR 20-F · filed 2020-03-31 |